aluates Reports

$ 0.0

Automative

Global Antibody Drug Conjugates Contract Manufacturing Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-23N13123

Global Antibody Drug Conjugates Contract Manufacturing Market Research Report 2023

BUY CHAPTERS

Global Antibody Drug Conjugates Contract Manufacturing Market Research Report 2025

Code: QYRE-Auto-23N13123

Report

March 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Lonza Group

Piramal Pharma Solutions

AbbVie

Novasep

Recipharm

Thermo Fisher Scientific

Cerbios-Pharma

Sterling Pharma Solutions

Ajinomoto Bio-Pharma Services

BSP Pharmaceuticals

Goodwin Biotechnology

Merck KGaA

Catalent

Curia

Antibody Drug Conjugates Contract Manufacturing Market Size

The global market for Antibody Drug Conjugates Contract Manufacturing was valued at US$ 3863 million in the year 2024 and is projected to reach a revised size of US$ 12780 million by 2031, growing at a CAGR of 18.9% during the forecast period.

Antibody Drug Conjugates Contract Manufacturing Market

ADCs are mainly composed of three parts: antibodies, linkers, and cytotoxic loads. They are a type of bioactive cytotoxic drugs that are linked to monoclonal antibodies through chemical bonds and use monoclonal antibodies as carriers to target and transport cytotoxic drugs to target cells. Complex that works. The design concept of ADC was first proposed by Paul Ehrlich in the early 20th century. In 2000, the U.S. Food and Drug Administration (FDA) approved the first ADC drug, Mylotarg® (gemtuzumab ozogamicin), for the treatment of acute myeloid myelopathy in adults. Leukemic cell lines, marking the beginning of the era of ADC-targeted cancer therapy.

Key global companies of Antibody Drug Conjugates Contract Manufacturing (ADC) include Lonza, Merck, Recipharm, Thermo Fisher, AbbVie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions and Curia. The top three players are Lonza, Merck and Recipharm, which together account for about 50% of the global market share. The largest player is Lonza Group. From the production side, the global players are mainly concentrated in North America and Europe. North America accounts for about 35% of the global market share. In terms of type, IgG1 dominates the global antibody drug conjugate contract manufacturing market. In terms of application, solid tumor applications account for more than half of the market.

This report aims to provide a comprehensive presentation of the global market for Antibody Drug Conjugates Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drug Conjugates Contract Manufacturing.

The Antibody Drug Conjugates Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Drug Conjugates Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibody Drug Conjugates Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antibody Drug Conjugates Contract Manufacturing Market Report

Report Metric	Details
Report Name	Antibody Drug Conjugates Contract Manufacturing Market
Accounted market size in year	US$ 3863 million
Forecasted market size in 2031	US$ 12780 million
CAGR	18.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	IgG1 IgG4
Segment by Application	Solid Tumors Hematological Malignancies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, Curia, Novasep, Ajinomoto Bio-Pharma Services, BSP Pharmaceuticals, Cerbios-Pharma, Goodwin Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Drug Conjugates Contract Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Antibody Drug Conjugates Contract Manufacturing Market growing?

Ans: The Antibody Drug Conjugates Contract Manufacturing Market witnessing a CAGR of 18.9% during the forecast period 2025-2031.

What is the Antibody Drug Conjugates Contract Manufacturing Market size in 2031?

Ans: The Antibody Drug Conjugates Contract Manufacturing Market size in 2031 will be US$ 12780 million.

What is the Recipharm share in Antibody Drug Conjugates Contract Manufacturing Market?

Ans: The top three players are Lonza, Merck and Recipharm, which together account for about 50% of the global market share.

What is the Antibody Drug Conjugates Contract Manufacturing Market share by region?

Ans: North America accounts for about 35% of the global market share.

Who are the main players in the Antibody Drug Conjugates Contract Manufacturing Market report?

Ans: The main players in the Antibody Drug Conjugates Contract Manufacturing Market are Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, Curia, Novasep, Ajinomoto Bio-Pharma Services, BSP Pharmaceuticals, Cerbios-Pharma, Goodwin Biotechnology

What are the Application segmentation covered in the Antibody Drug Conjugates Contract Manufacturing Market report?

Ans: The Applications covered in the Antibody Drug Conjugates Contract Manufacturing Market report are Solid Tumors, Hematological Malignancies

What are the Type segmentation covered in the Antibody Drug Conjugates Contract Manufacturing Market report?

Ans: The Types covered in the Antibody Drug Conjugates Contract Manufacturing Market report are IgG1, IgG4

Recommended Reports

Antibody Drug Conjugates

Contract Manufacturing

Antibody and Cancer Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 IgG1

1.2.3 IgG4

1.3 Market by Application

1.3.1 Global Antibody Drug Conjugates Contract Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Solid Tumors

1.3.3 Hematological Malignancies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Perspective (2020-2031)

2.2 Global Antibody Drug Conjugates Contract Manufacturing Growth Trends by Region

2.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Region (2020-2025)

2.2.3 Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2026-2031)

2.3 Antibody Drug Conjugates Contract Manufacturing Market Dynamics

2.3.1 Antibody Drug Conjugates Contract Manufacturing Industry Trends

2.3.2 Antibody Drug Conjugates Contract Manufacturing Market Drivers

2.3.3 Antibody Drug Conjugates Contract Manufacturing Market Challenges

2.3.4 Antibody Drug Conjugates Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antibody Drug Conjugates Contract Manufacturing Players by Revenue

3.1.1 Global Top Antibody Drug Conjugates Contract Manufacturing Players by Revenue (2020-2025)

3.1.2 Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Players (2020-2025)

3.2 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antibody Drug Conjugates Contract Manufacturing Revenue

3.4 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio

3.4.1 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugates Contract Manufacturing Revenue in 2024

3.5 Global Key Players of Antibody Drug Conjugates Contract Manufacturing Head office and Area Served

3.6 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application

3.7 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Type

4.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Type (2020-2025)

4.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2026-2031)

5 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Application

5.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Application (2020-2025)

5.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size (2020-2031)

6.2 North America Antibody Drug Conjugates Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2020-2025)

6.4 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size (2020-2031)

7.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2020-2025)

7.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size (2020-2031)

8.2 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2020-2025)

8.4 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antibody Drug Conjugates Contract Manufacturing Market Size (2020-2031)

9.2 Latin America Antibody Drug Conjugates Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2020-2025)

9.4 Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size (2020-2031)

10.2 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2020-2025)

10.4 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza Group

11.1.1 Lonza Group Company Details

11.1.2 Lonza Group Business Overview

11.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Introduction

11.1.4 Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.1.5 Lonza Group Recent Development

11.2 Merck KGaA

11.2.1 Merck KGaA Company Details

11.2.2 Merck KGaA Business Overview

11.2.3 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Introduction

11.2.4 Merck KGaA Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.2.5 Merck KGaA Recent Development

11.3 Recipharm

11.3.1 Recipharm Company Details

11.3.2 Recipharm Business Overview

11.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Introduction

11.3.4 Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.3.5 Recipharm Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Introduction

11.4.4 Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Abbvie

11.5.1 Abbvie Company Details

11.5.2 Abbvie Business Overview

11.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Introduction

11.5.4 Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.5.5 Abbvie Recent Development

11.6 Piramal Pharma Solutions

11.6.1 Piramal Pharma Solutions Company Details

11.6.2 Piramal Pharma Solutions Business Overview

11.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction

11.6.4 Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.6.5 Piramal Pharma Solutions Recent Development

11.7 Catalent

11.7.1 Catalent Company Details

11.7.2 Catalent Business Overview

11.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Introduction

11.7.4 Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.7.5 Catalent Recent Development

11.8 Sterling Pharma Solutions

11.8.1 Sterling Pharma Solutions Company Details

11.8.2 Sterling Pharma Solutions Business Overview

11.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction

11.8.4 Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.8.5 Sterling Pharma Solutions Recent Development

11.9 Curia

11.9.1 Curia Company Details

11.9.2 Curia Business Overview

11.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Introduction

11.9.4 Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.9.5 Curia Recent Development

11.10 Novasep

11.10.1 Novasep Company Details

11.10.2 Novasep Business Overview

11.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Introduction

11.10.4 Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.10.5 Novasep Recent Development

11.11 Ajinomoto Bio-Pharma Services

11.11.1 Ajinomoto Bio-Pharma Services Company Details

11.11.2 Ajinomoto Bio-Pharma Services Business Overview

11.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Introduction

11.11.4 Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.11.5 Ajinomoto Bio-Pharma Services Recent Development

11.12 BSP Pharmaceuticals

11.12.1 BSP Pharmaceuticals Company Details

11.12.2 BSP Pharmaceuticals Business Overview

11.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Introduction

11.12.4 BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.12.5 BSP Pharmaceuticals Recent Development

11.13 Cerbios-Pharma

11.13.1 Cerbios-Pharma Company Details

11.13.2 Cerbios-Pharma Business Overview

11.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Introduction

11.13.4 Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.13.5 Cerbios-Pharma Recent Development

11.14 Goodwin Biotechnology

11.14.1 Goodwin Biotechnology Company Details

11.14.2 Goodwin Biotechnology Business Overview

11.14.3 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Introduction

11.14.4 Goodwin Biotechnology Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

11.14.5 Goodwin Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Lonza Group

Piramal Pharma Solutions

AbbVie

Novasep

Recipharm

Thermo Fisher Scientific

Cerbios-Pharma

Sterling Pharma Solutions

Ajinomoto Bio-Pharma Services

BSP Pharmaceuticals

Goodwin Biotechnology

Merck KGaA

Catalent

Curia

List of Tables

Table 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of IgG1

Table 3. Key Players of IgG4

Table 4. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2020-2025)

Table 8. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2026-2031)

Table 10. Antibody Drug Conjugates Contract Manufacturing Market Trends

Table 11. Antibody Drug Conjugates Contract Manufacturing Market Drivers

Table 12. Antibody Drug Conjugates Contract Manufacturing Market Challenges

Table 13. Antibody Drug Conjugates Contract Manufacturing Market Restraints

Table 14. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players (2020-2025)

Table 16. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2024)

Table 17. Ranking of Global Top Antibody Drug Conjugates Contract Manufacturing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Headquarters and Area Served

Table 20. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application

Table 21. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2020-2025)

Table 25. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2026-2031)

Table 27. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2020-2025)

Table 29. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2026-2031)

Table 31. North America Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Lonza Group Company Details

Table 47. Lonza Group Business Overview

Table 48. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product

Table 49. Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 50. Lonza Group Recent Development

Table 51. Merck KGaA Company Details

Table 52. Merck KGaA Business Overview

Table 53. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product

Table 54. Merck KGaA Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 55. Merck KGaA Recent Development

Table 56. Recipharm Company Details

Table 57. Recipharm Business Overview

Table 58. Recipharm Antibody Drug Conjugates Contract Manufacturing Product

Table 59. Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 60. Recipharm Recent Development

Table 61. Thermo Fisher Scientific Company Details

Table 62. Thermo Fisher Scientific Business Overview

Table 63. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product

Table 64. Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 65. Thermo Fisher Scientific Recent Development

Table 66. Abbvie Company Details

Table 67. Abbvie Business Overview

Table 68. Abbvie Antibody Drug Conjugates Contract Manufacturing Product

Table 69. Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 70. Abbvie Recent Development

Table 71. Piramal Pharma Solutions Company Details

Table 72. Piramal Pharma Solutions Business Overview

Table 73. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product

Table 74. Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 75. Piramal Pharma Solutions Recent Development

Table 76. Catalent Company Details

Table 77. Catalent Business Overview

Table 78. Catalent Antibody Drug Conjugates Contract Manufacturing Product

Table 79. Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 80. Catalent Recent Development

Table 81. Sterling Pharma Solutions Company Details

Table 82. Sterling Pharma Solutions Business Overview

Table 83. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product

Table 84. Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 85. Sterling Pharma Solutions Recent Development

Table 86. Curia Company Details

Table 87. Curia Business Overview

Table 88. Curia Antibody Drug Conjugates Contract Manufacturing Product

Table 89. Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 90. Curia Recent Development

Table 91. Novasep Company Details

Table 92. Novasep Business Overview

Table 93. Novasep Antibody Drug Conjugates Contract Manufacturing Product

Table 94. Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 95. Novasep Recent Development

Table 96. Ajinomoto Bio-Pharma Services Company Details

Table 97. Ajinomoto Bio-Pharma Services Business Overview

Table 98. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product

Table 99. Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 100. Ajinomoto Bio-Pharma Services Recent Development

Table 101. BSP Pharmaceuticals Company Details

Table 102. BSP Pharmaceuticals Business Overview

Table 103. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product

Table 104. BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 105. BSP Pharmaceuticals Recent Development

Table 106. Cerbios-Pharma Company Details

Table 107. Cerbios-Pharma Business Overview

Table 108. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product

Table 109. Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 110. Cerbios-Pharma Recent Development

Table 111. Goodwin Biotechnology Company Details

Table 112. Goodwin Biotechnology Business Overview

Table 113. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product

Table 114. Goodwin Biotechnology Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025) & (US$ Million)

Table 115. Goodwin Biotechnology Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Antibody Drug Conjugates Contract Manufacturing Picture

Figure 2. Global Antibody Drug Conjugates Contract Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Type: 2024 VS 2031

Figure 4. IgG1 Features

Figure 5. IgG4 Features

Figure 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application: 2024 VS 2031

Figure 8. Solid Tumors Case Studies

Figure 9. Hematological Malignancies Case Studies

Figure 10. Antibody Drug Conjugates Contract Manufacturing Report Years Considered

Figure 11. Global Antibody Drug Conjugates Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Antibody Drug Conjugates Contract Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region: 2024 VS 2031

Figure 14. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players in 2024

Figure 15. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue in 2024

Figure 17. North America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2020-2031)

Figure 19. United States Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2020-2031)

Figure 23. Germany Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2020-2031)

Figure 31. China Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2020-2031)

Figure 39. Mexico Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2020-2031)

Figure 43. Turkey Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Lonza Group Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 47. Merck KGaA Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 48. Recipharm Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 50. Abbvie Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 51. Piramal Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 52. Catalent Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 53. Sterling Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 54. Curia Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 55. Novasep Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 56. Ajinomoto Bio-Pharma Services Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 57. BSP Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 58. Cerbios-Pharma Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 59. Goodwin Biotechnology Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Antibody drug Conjugate for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibody drug Conjugates Market Insights Forecast to 2030

Global Monoclonal Antibody ADC Drugs Market Research Report 2025

Global Antibody drug Conjugates for Tumors Market Research Report 2024

Global Antibody Drug Conjugate CDMO Market Research Report 2024

Global Antibody drug Conjugate ADC Payload Market Research Report 2025

Global HER2 Antibody Drug Conjugate Market Research Report 2025

Global ADC Drug CDMO Service Market Research Report 2024

Antibody Drug Conjugate ADC Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global ADC Manufacturing Service Market Research Report 2025

Global HER2 ADC Drugs Market Research Report 2024

Global Highly Potent API HPAPI For Antibody drug Conjugate ADC Market Research Report 2025

ADC Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibody drug Conjugates ADCs CMO and CDMO Market Research Report 2025

Global Antibody Oligonucleotide Conjugates AOC Drug Market Research Report 2024

Global Next Generation Monoclonal Antibodies Market Research Report 2024

Global Peptide Drug Conjugates PDCs CDMO Service Market Research Report 2024

Global Next Generation Antibody Therapeutics Market Research Report 2025

Global Antibody radionuclide Conjugates Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions